Psychology

Recurrent Depression Showed Directional Brain Connectivity Imbalance

June 29, 2026 by BrainASAP

TL;DR: A 2026 preprint in medRxiv linked recurrent major depression to direction-specific effective-connectivity changes, with strongest patterns in cerebellar-cortical, sensorimotor, cognitive, neurotransmitter, and oligodendrocyte precursor cell maps. Key Findings 1,627-person discovery dataset: REST-meta-MDD resting-state functional MRI (fMRI) and T1 MRI data compared 839 people with major depression and 788 controls. Recurrent depression pattern: First-episode drug-naive …

PReDicT Antidepressant Algorithm Had Uncertain Cost-Effectiveness

July 9, 2026June 29, 2026 by BrainASAP

TL;DR: A 2026 study in BJPsych Open found that closely monitored antidepressant care improved quality of life and reduced societal costs in both PReDicT and usual-care groups, while the PReDicT algorithm added uncertain, country-dependent economic value. Key Findings Multinational trial data anchored the analysis: The economic evaluation followed 913 patients in France, Germany, the Netherlands, …

Drosophila Dopamine Signaling Sustained Stress-Induced Courtship Suppression

June 29, 2026 by BrainASAP

TL;DR: A 2026 study in iScience found that 1 hour of small-space confinement suppressed male courtship in Drosophila, and dopamine signaling into the mushroom body was needed to keep that suppression going after the stress ended. Key Findings 1-hour stress model: Male flies confined in a 3 mm by 2 mm small-space chamber showed reduced …

Agomelatine Improved Subjective Sleep Quality but Not Objective Sleep Time

June 29, 2026 by BrainASAP

TL;DR: A 2026 systematic review and meta-analysis in Journal of Sleep Research found that agomelatine modestly improved subjective sleep quality versus placebo, but objective total sleep time did not significantly increase and somnolence reports were more frequent. Key Findings 25 RCTs: The review included 25 double-blind randomized controlled trials with 6,812 randomized participants. Subjective sleep …

miR-425-3p Review Links Depression Biomarker Candidate to MAPK and Wnt Pathways

June 29, 2026 by BrainASAP

TL;DR: A 2026 review in Neuropsychiatric Disease and Treatment argues that miR-425-3p is a candidate depression biomarker because it connects stress biology, MAPK/Wnt signaling, inflammation, and antidepressant response evidence. Key Findings 280 million MDD burden: The review opens from the scale of major depressive disorder, which affects more than 280 million people worldwide. About 20-fold …

EHR NLP Study Found 46% Treatment-Resistant Depression in Belgian MDD Cohort

July 9, 2026June 28, 2026 by BrainASAP

TL;DR: A 2026 study in Interactive Journal of Medical Research used structured hospital records plus natural language processing of clinical notes to profile major depressive disorder in Belgium, finding that 46% of 1,147 adults met a real-world treatment-resistant depression definition. Key Findings Belgian EHR cohort: The retrospective study drew from 1,147 adults with major depressive …

iSupport-Malaysia Dementia Caregiver Platform Scored Above Usability Benchmark

June 28, 2026 by BrainASAP

TL;DR: A 2026 preprint posted on medRxiv found that iSupport-Malaysia, a culturally adapted multimedia dementia-caregiver platform, scored above the usual usability benchmark and was viewed as culturally appropriate by caregivers and healthcare professionals. Key Findings Four-phase adaptation: The WHO iSupport dementia program was translated into Bahasa Malaysia, culturally adapted, and rebuilt as multimedia e-learning. 23 …

Indoleacrylic Acid Linked to PFO-Migraine Metabolomics

June 28, 2026 by BrainASAP

TL;DR: A 2026 study in iScience found that migraine patients with patent foramen ovale had altered plasma metabolic profiles, with lower indoleacrylic acid and an IA-plus-hs-CRP marker pair showing exploratory discrimination in a validation cohort. Key Findings 30 discovery patients: Untargeted metabolomics compared 30 migraine patients with patent foramen ovale against 17 matched controls. 4,858 …

Smoking-Cessation Medications Show Limited Trial Evidence in Indigenous Adults

July 9, 2026June 28, 2026 by BrainASAP

TL;DR: A 2026 systematic review in Preventive Medicine Reports found limited but suggestive randomized-trial evidence that smoking-cessation medications can help Indigenous adults quit, especially when paired with supportive or culturally tailored care. Key Findings 5 RCTs: The review found only 5 randomized controlled trials, totaling 1,633 participants, in American Indian, Alaska Native, and Maori adult …

Robot Utterances Shaped Human-Robot Relationship Expectations More Than Appearance

July 9, 2026June 28, 2026 by BrainASAP

TL;DR: A 2026 Scientific Reports study found that a robot’s utterances shaped expected human-robot relationship structure far more than the robot’s physical appearance in Japanese online scenario experiments. Key Findings Nine pictograms: Researchers built a nine-pictogram questionnaire to capture perceived relationship structures such as balanced contribution, one-sided service, and shared goals. 510-person validation sample: Survey …

+ Load more